Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression

M.J. Wondergem; S.J. Stevens; J.J.W.M. Janssen; J.J. Oudejans; G.J. Ossenkoppele; J.M. Middeldorp; S. Zweegman

doi:https://doi.org/10.1182/blood-2007-09-111534

Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression

M.J. Wondergem, S.J. Stevens, J.J.W.M. Janssen, J.J. Oudejans, G.J. Ossenkoppele, J.M. Middeldorp, S. Zweegman

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1739-1740
Journal	Blood
Volume	111
Issue number	3
DOIs	https://doi.org/10.1182/blood-2007-09-111534
Publication status	Published - 2008

Access to Document

https://doi.org/10.1182/blood-2007-09-111534

Cite this

@article{142f9cbe49f74f5db644f40895290956,

title = "Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression",

author = "M.J. Wondergem and S.J. Stevens and J.J.W.M. Janssen and J.J. Oudejans and G.J. Ossenkoppele and J.M. Middeldorp and S. Zweegman",

year = "2008",

doi = "https://doi.org/10.1182/blood-2007-09-111534",

language = "Undefined/Unknown",

volume = "111",

pages = "1739--1740",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "3",

}

TY - JOUR

T1 - Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression

AU - Wondergem, M.J.

AU - Stevens, S.J.

AU - Janssen, J.J.W.M.

AU - Oudejans, J.J.

AU - Ossenkoppele, G.J.

AU - Middeldorp, J.M.

AU - Zweegman, S.

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1182/blood-2007-09-111534

DO - https://doi.org/10.1182/blood-2007-09-111534

M3 - Article

C2 - 18223173

SN - 0006-4971

VL - 111

SP - 1739

EP - 1740

JO - Blood

JF - Blood

IS - 3

ER -